Platelet Function in Acute Myocardial Infarction Patients Compared with Controls

Summary

A considerable number of tests were carried out comparing 33 patients with acute myocardial infarction (MI), 13 patients with chest pain (CP) and 47 controls. There was some evidence that the plasma platelet factor 4 (PF4) was different in the three groups. The heparin neutralizing activity (HNA) of platelet poor plasma was increased in the MI patients relative to the controls and the intra-platelet HNA was decreased. Malondialdehyde (MDA) formation by platelets maximally stimulated by thrombin was decreased in MI whilst the plasma 5-hydroxyindoles (5HIs) in MI was greatly increased. The acute phase proteins α₁ acid glycoprotein and fibrinogen were significantly raised in MI. The results in the CP group were intermediate between the MI and the controls. These findings define more precisely the changes in acute MI and are relevant to the concept of exhausted platelets.

Key words

Myocardial infarct - Heparin neutralizing activity - Platelet factor 4 - Serotonin - Exhausted platelets

• References

• 1 Handin RI, McDonough M, Lesch M. Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med 1978; 91: 340-349
• 2 Ludlam CA, O'Brien JR, Bolton AE, Etherington MD. A comparison between the plasma concentration of immunologically assayed platelet factor four and β-thromboglobulin and the heparin thrombin clotting time. Thromb Res 1979; 15: 523-530
• 3 Andersen P, Godal HC. The anti-heparin effect of α₁acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time. Haemostasis 1977; 6: 339-346
• 4 Holger-Madsen T. Reduction of heparin activity by plasma globulins in patients with increased heparin resistance. Acta Haemat 1962; 27: 157-170
• 5 O'Brien JR, Etherington MD, Jamieson S, Lawford P, Sussex J, Lincoln SV. Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Path 1975; 28: 975-979
• 6 O'Brien JR, Etherington MD. An inverse relation between platelet factor four in the platelet and in the plasma. Thromb Haemostas 1976; 36: 649-651
• 7 McMillan RM, MacIntyre DE, Gordon JL. Simple, sensitive fluorometric assay for malondialdehyde production by blood platelets. Thromb Res 1977; 2: 425-428
• 8 Stuart M, Murphy S, Oski EA. A simple, non-radio-isotope technic for the determination of platelet life span. New Engl J Med 1975; 292: 1310-1313
• 9 Clauss A. Gerrinnunge Physiologische Schneilmethode Zur Beskinnung Des Fibrinogens. Acta Haemat (Bale) 1957; 17: 237-246
• 10 Parbtani A, Cameron JS. Platelet and plasma serotonin concentrations in glomerulonephritis I. Thromb Res 1979; 15: 109-125
• 11 Shuttleworth RD, O'Brien JR. Intra-platelet serotonin and plasma 5-hydroxyindoles in health and disease. In preparation
• 12 Reimers HJ, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol 1973; 25: 675-689
• 13 O'Brien JR. "Exhausted" platelets continue to circulate. Lancet 1978; II: 1316-1317
• 14 Hawiger J, Collings RD, Horn RG. Precipitation of soluble fibrin monomer complexes by lysosomal fraction of polymorphonuclear leucocytes. Proc Soc Exp Biol Med 1969; 131: 349-353
• 15 Dawes J, Smith RC, Pepper DS. The release, distribution and clearance of Human β-Thromboglobulin and Platelet Factor Four. Thromb Res 1978; 12: 851-861